Welcome to the official Blog of "Insulin Potentiation Targeted Therapy" a medical procedure in Alternative Medicine, developed and researched for over 80 years by 3 generations of medical doctors, named Donato Pérez García.

Wednesday, April 8, 2015

Timing of cancer chemotherapy using IPTLD® is crucial for the success of treatment. By Donato Perez Garcia, MD (IPT/IPTLD® Professor)

Timing of cancer chemotherapy using
IPTLD® is crucial for the success of treatment. By Donato Perez Garcia, MD
(IPT/IPTLD® Professor)

Back in the year 1980, R. North an
immunologist from the Trudeau Institute in New York and colleagues were able to
produce immune cycling with tumor regression by directing chemotherapy to
immune suppressor cells. He also reported that if chemotherapy was given at the
wrong day and earlier, it will not work, instead the tumor will grow faster and
will give the impression that the tumor was resistant to the chemotherapy drug.
(Science Magazine,May 2010).

While several of the IPT doctors I
have trained on Insulin Potentiation Therapy(IPT)and some patients who have
a cancer recurrence are concerned with finding which chemotherapy drug will
work best I tell them that to have a successful treatment of cancer depends on
the accurate timing of delivering chemotherapy to match the fluctuation in each
patient's immune system.

Not all cancer patients are cured
by surgery, radiotherapy, biological therapies, alternative treatments,
standard high dose chemotherapy or even low dose chemo. Some patients achieve a
complete regression, others do not respond and others appear to have some level
of clinical response.

Traditional cancer therapies affect
some cancer cells but also normal cells and produce the well known side
effects.

Today my Insulin Potentiation
Therapy +Targeted Low Dose chemotherapy has been taking advantage of the immune
system cycle using it regulatory mechanism by enhancing selectively the T cells
in a cycle specific manner due to the actions of the insulin that acts as a
modifier of the cell biologic response.

Since Donato Perez Garcia,MD
(1896-1971) the inventor on this treatment for cancer and chronic degenerative
diseases started to treat patients, he set the treatment appointments for every
7 days, this was back in the year 1930 for chronic degenerative diseases and in
1946 for cancer. He noted that patients had very good responses when they
received their chemotherapy every 7 days. It was the time when observation and
good clinical judgment played an important factor. His observations came to
scientific support until the year 2009 when a team of Medical Doctors
(Coventry,Ashdown,Quinn,Markovic,Yatomi-Clarke & Robinson) fromDepartment of Surgery & Tumor Immunology
Laboratory, University of Adelaide, Royal Adelaide Hospital, Adelaide South
Australia identified the homeostatic immune oscillations in cancer patients
that CRP a protein indicated. This CRP is associated with inflammation and the
activation of the immune system. (Journal of Translational Medicine 2009,7:102)

To my patients treated here in
Tijuana,Baja California this means that they are receiving their chemotherapy
protocol on the correct day, achieving the disruption of the regulatory
circuits that protect the tumor cells.With my IPTLD protocol my patients are also taking advantage of the
induced and controlled hyperthermia that insulin produces and it is well known
that a high body temperature also helps in the fight against cancer.

I started to treat cancer and
chronic degenerative disease patients back in 1983 and during these 28 years or
clinical practice I have seen several cancer patients that were initially
treated with standard chemotherapy, responded well but later developed a cancer
recurrence. Several of these patients who developed a metastases or recurrence
were told thatthey build chemo
resistance. When I started to treat them using the low dose insulin that acts
as a modifier of the cell biologic response with the same chemo drugs they
received as their first treatment they all had a good response. No need to
mention that the Greek test to detect chemotherapeutic drugs sensitivity was
not available.

Conclusion it is more important to
deliver your chemotherapy drug combination on the right time and day to match
your immune system activity . It is a good help to know which drugs
"can" "maybe" work by means of a chemo sensitivity test but
definitely it is not critical to your treatment, because when the drugs are
given on the right time and day the response is going to be a success.